Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cottbus
Clinical trial register · Germany

Clinical Trials in Cottbus, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2869
Recruiting now
open to new participants
983
Lead sponsors
across recruiting studies
Top sites
Berlin 1587 Hamburg 893 Essen 765 Dresden 714 Heidelberg 626
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals4 AstraZeneca3 University of Leipzig3 Hoffmann-La Roche3 Merck Sharp & Dohme LLC3 Janssen Research & Development, LLC2 Pfizer2 AbbVie1 Martin Schrappe1 UNICANCER1 German Society for Pediatric Oncology and Hematology GPOH gGmbH1 BioMarin Pharmaceutical1 Eli Lilly and Company1 Zoll Medical Corporation1 Bristol-Myers Squibb1 Denali Therapeutics Inc.1 Toralf Reimer, MD PhD1 Incyte Corporation1 University Hospital, Basel, Switzerland1 Upstream Bio Inc.1 Teva Branded Pharmaceutical Products R&D LLC1 Chiesi Farmaceutici S.p.A.1 Women's Cancer Study Group GmbH1 UMC Utrecht1 GBG Forschungs GmbH1 Show all 27
Site location
Berlin1587 Hamburg893 Essen765 Dresden714 Heidelberg626 Cologne619 Leipzig513 München510 Hanover487 Tübingen454 Bonn422 Düsseldorf409 Munich398 Freiburg im Breisgau394 Erlangen374 Frankfurt369 Münster359 Frankfurt am Main343 Ulm343 Mainz336 Würzburg296 Aachen266 Augsburg248 Kiel234 Lübeck225 Show all 638
All 638 locations
Target enrolment
to

Trials with a site in Cottbus

40 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
Women's Cancer Study Group GmbH
Phase 3
765
Heilbronn, Weinheim, Augsburg, München, Regensburg, Würzburg, Cottbus, Bad Nauheim
2026-08-30
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Mannheim, Jena, Aachen, Cottbus, Erlangen, Hamburg, Hanover, Minden
2026-05-27
Recruiting
Eli Lilly and Company
Phase 2
600
Bergisch Gladbach, Berlin, Bielefeld, Bochum, Bonn, Bottrop, Bremen, Cottbus
2026-05-13
Active, closed
Merck Sharp & Dohme LLC
Phase 2
140
Cottbus, Herne, Berlin, Hamburg
2026-04-20
Active, closed
Janssen Research & Development, LLC
Phase 2
157
Bad Bentheim, Berlin, Cottbus, Hamburg, Heidelberg, Mainz, Remscheid, Witten
2026-01-15
Recruiting
UNICANCER
Phase 3
3,902
Aachen, Augsburg, Bad Nauheim, Berlin, Bremen, Cottbus, Dresden, Düsseldorf
2025-12-18
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 2
780
Ahrensburg, Berlin, Cottbus, Delitzsch, Düsseldorf, Hamburg, Ibbenbueren, Leipzig
2025-12-17
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Freiburg im Breisgau, Mannheim, Munich, Unterhaching, Cottbus, Leipzig, Halle, Jena
2025-11-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
185
München, Cottbus, Ratingen, Berlin, Hamburg
2025-10-08
Recruiting
Merck Sharp & Dohme LLC
Phase 2
315
Munich, Cottbus, Herne, Ratingen, Berlin, Hamburg
2025-09-26
Recruiting
AbbVie
Phase 3
120
Cottbus, Kassel, Münster
2025-07-28
Active, closed
Upstream Bio Inc.
Phase 2
666
Aschaffenburg, Augsburg, Bamberg, München, Cottbus, Hamburg, Darmstadt, Frankfurt am Main
2025-07-02
Recruiting
GBG Forschungs GmbH
Phase 2
120
Augsburg, Berlin, Bielefeld, Bremen, Cologne, Cottbus, Dortmund, Essen
2024-12-04
Active, closed
AstraZeneca
Phase 3
310
Augsburg, Bonn, Cottbus, Hanover, Mainz
2024-09-30
Recruiting
Prospective WCD Post CABG Registry (CABG Registry)
NCT06570902Cardiomyopathy Ischemic, Cardiomyopathies, Cardiovascular Diseases, Heart Disease, Ischemic
Zoll Medical Corporation
Observational
910
Bad Nauheim, Hanover, Cottbus, Halle
2024-09-23
Recruiting
Novartis Pharmaceuticals
Observational
500
Konstanz, Stuttgart, Munich, Regensburg, Würzburg, Cottbus, Frankfurt (Oder), Ludwigshafen
2024-09-04
Recruiting
AstraZeneca
Observational
300
Ahrensburg, Ansbach, Aschaffenburg, Auerbach, Augsburg, Bad Homburg, Berlin, Cottbus
2024-07-25
Recruiting
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
NCT07777744Ventricular Tachycardia (VT), Premature Ventricular Complexes
University Hospital, Basel, Switzerland
Observational
15,000
Bad Berka, Bad Krozingen, Cottbus, Münster
2024-07-01
Recruiting
AstraZeneca
Phase 3
5,250
Ahrensburg, Augsburg, Bamberg, Berlin, Bonn, Bremen, Cottbus, Dachau
2024-02-21
Recruiting
Pfizer
Phase 3
492
Freiburg im Breisgau, Stuttgart, Ulm, Nuremberg, Bonn, Berlin, Cottbus, Hamm
2024-02-08
Recruiting
University of Leipzig
Phase 3
188
Borna, Cottbus, Essen, Freiburg im Breisgau, Hamburg, Heidelberg, Jena, Leipzig
2024-01-24
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,769
Augsburg, Berlin, Cottbus, Darmstadt, Delitzsch, Essen, Frankfurt, Frankfurt am Main
2023-08-30
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Ulm, Augsburg, Bayreuth, Erlangen, Munich, Cottbus, Hamburg, Chemnitz
2023-06-22
Active, closed
University of Leipzig
Phase 2
45
Berlin, Chemnitz, Cottbus, Dresden, Heidelberg, Leipzig, Mönchengladbach, München
2023-05-17
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Cottbus, Dresden, Greifswald, Hamburg, Heidelberg, Marburg, Tübingen, Ulm
2023-03-29
Recruiting
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
NCT06019130Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Neoplasms, Nasopharynx Cancer
DrugsAvonex·Opdivo·Adrucil·Nivolumab
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Phase 2
57
Aachen, Berlin, Bielefeld, Bonn, Cologne, Cottbus, Dortmund, Dresden
2023-01-10
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Erlangen, Trier, Würzburg, Cottbus, Potsdam, Frankfurt am Main, Hanover, Greifswald
2022-11-21
Recruiting
University of Leipzig
Phase 2
213
Berlin, Bonn, Cottbus, Erlangen, Greifswald, Hamburg, Kassel, Koblenz
2022-09-27
Active, closed
Denali Therapeutics Inc.
Phase 2/3
65
Höchheim, Cottbus
2022-07-21
Recruiting
BioMarin Pharmaceutical
Observational
450
Cottbus, Hamburg, Leipzig, Mainz, Münster, Ulm
2022-06-06
Recruiting
University Medicine Greifswald
Observational
3,000
Aachen, Berlin, Bonn, Braunschweig, Chemnitz, Cologne, Cottbus, Düsseldorf
2021-08-06
Active, closed
Hoffmann-La Roche
Phase 3
451
Bonn, Cologne, Cottbus, Freiburg im Breisgau, Hamburg, Ludwigshafen, München, Münster
2021-07-14
Active, closed
Incyte Corporation
Phase 3
899
Aachen, Augsburg, Berlin, Bonn, Chemnitz, Cottbus, Göttingen, Halle
2021-05-11
Active, closed
Toralf Reimer, MD PhD
Not applicable
350
Augsburg, Baden-Baden, Berlin, Bochum, Borna, Bottrop, Böblingen, Cottbus
2021-01-13
Active, closed
Pfizer
Observational
1,407
Bayreuth, Nuremberg, Cottbus, Goslar, Bonn, Bad Mergentheim, Berlin, Bremen
2020-10-27
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Ravensburg, Munich, Würzburg, Cottbus, Frankfurt am Main, Georgsmarienhütte, Hanover, Essen
2018-12-07
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Bonn, Cologne, Cottbus, Freiburg im Breisgau, Hamburg, Ludwigshafen, München, Münster
2018-09-20
Recruiting
Martin Schrappe
Phase 3
5,000
Aachen, Augsburg, Berlin, Braunschweig, Chemnitz, Cologne, Cottbus, Datteln
2018-07-15
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707Respiratory Tract Diseases, Influenza (Pandemic), Influenza, Community Acquired Pneumonia
DrugsConvalescent plasma·Repagermanium·Ivermectin·Telmisartan
UMC Utrecht
Phase 3
20,000
Berlin, Cologne, Cottbus, Dortmund, Essen, Frankfurt, Hamburg, Jena
2016-04-11
Recruiting
University of Giessen
Phase 2/3
210
Ansbach, Aschaffenburg, Bad Neustadt an der Saale, Berlin, Bremen, Celle, Cottbus, Darmstadt
2004-05
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-germany/city/cottbus

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies with a site in Cottbus.

How many clinical trials are recruiting in Cottbus?

23 of the 40 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cottbus), 40 studies
PhaseStudiesRecruitingShare
Phase 3181045%
Phase 211627.5%
Observational8620%
Phase 2/3215%
Not applicable102.5%

Most active sponsors

Lead sponsors with the most studies (Cottbus)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals43
AstraZeneca32
Hoffmann-La Roche31
Merck Sharp & Dohme LLC31
University of Leipzig32
Janssen Research & Development, LLC20
Pfizer21
AbbVie11
BioMarin Pharmaceutical11
Bristol-Myers Squibb10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.